Informations:
Erreur:
ID
28486
Description
Effect of Abrupt Plavix® Discontinuation on Platelet Function; ODM derived from: https://clinicaltrials.gov/show/NCT00670943
Lien
https://clinicaltrials.gov/show/NCT00670943
Mots-clés
Versions (1)
- 17/01/2018 17/01/2018 -
Détendeur de droits
See clinicaltrials.gov
Téléchargé le
17 janvier 2018
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Coronary Artery Disease NCT00670943
Eligibility Coronary Artery Disease NCT00670943
- StudyEvent: Eligibility
Similar models
Eligibility Coronary Artery Disease NCT00670943
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Coronary Artery Disease Stable | Clopidogrel To be stopped | Placement of stent
Item
group 1: patients suffering from stable cad scheduled to discontinue clopidogrel therapy at least one month after stent implantation
boolean
C1956346 (UMLS CUI [1,1])
C0205360 (UMLS CUI [1,2])
C0070166 (UMLS CUI [2,1])
C1272691 (UMLS CUI [2,2])
C0522776 (UMLS CUI [3])
C0205360 (UMLS CUI [1,2])
C0070166 (UMLS CUI [2,1])
C1272691 (UMLS CUI [2,2])
C0522776 (UMLS CUI [3])
Coronary Artery Disease Stable | Clopidogrel naive
Item
group 2: stable clopidogrel-naïve cad patients
boolean
C1956346 (UMLS CUI [1,1])
C0205360 (UMLS CUI [1,2])
C0070166 (UMLS CUI [2,1])
C0919936 (UMLS CUI [2,2])
C0205360 (UMLS CUI [1,2])
C0070166 (UMLS CUI [2,1])
C0919936 (UMLS CUI [2,2])
Informed Consent
Item
patients willing to participate in the study and to sign the informed consent form
boolean
C0021430 (UMLS CUI [1])
Acute Coronary Syndrome | Revascularization
Item
acute coronary syndrome or revascularization in the last 3 months prior to enrolment
boolean
C0948089 (UMLS CUI [1])
C0581603 (UMLS CUI [2])
C0581603 (UMLS CUI [2])
Anti-Inflammatory Agents, Non-Steroidal | Cyclooxygenase 2 Inhibitors | Ticlopidine | Dipyridamole | Warfarin | Acenocoumarol
Item
concurrent ingestion of nonsteroidal anti-inflammatory drugs (nsaids, including cox-2 selective anti-inflammatory drugs), ticlopidine, dipyridamole, warfarin or acenocoumarol
boolean
C0003211 (UMLS CUI [1])
C1257954 (UMLS CUI [2])
C0040207 (UMLS CUI [3])
C0012582 (UMLS CUI [4])
C0043031 (UMLS CUI [5])
C0000956 (UMLS CUI [6])
C1257954 (UMLS CUI [2])
C0040207 (UMLS CUI [3])
C0012582 (UMLS CUI [4])
C0043031 (UMLS CUI [5])
C0000956 (UMLS CUI [6])
Major surgery
Item
major surgical procedure within 1 month before enrolment
boolean
C0679637 (UMLS CUI [1])
Platelet count abnormal
Item
platelet count outside the 100 000 to 450 000/μl range
boolean
C0580317 (UMLS CUI [1])
Hematocrit procedure | Hemoglobin measurement
Item
hematocrit < 25% or haemoglobin < 100 g/l
boolean
C0018935 (UMLS CUI [1])
C0518015 (UMLS CUI [2])
C0518015 (UMLS CUI [2])
Dialysis Chronic Kidney Failure
Item
patient undergoing dialysis for chronic renal failure
boolean
C0011946 (UMLS CUI [1,1])
C0022661 (UMLS CUI [1,2])
C0022661 (UMLS CUI [1,2])